Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|December 22, 2016
Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm ProcessDongyang Liu, Yi Zhang, Ji Jiang, et al.
Clinical Pharmacology in Drug Development|December 23, 2021
Pharmacokinetics of Sugammadex: An Open-Label, 3-Period, Fixed-Sequence, 3-Single-Doses Study in Healthy Chinese SubjectsFei Yuan, Mengjie Yang, Weili Chen, et al.
Frontiers in Veterinary Science|November 25, 2024
Changes in the growth performance, serum biochemistry, rumen fermentation, rumen microbiota community, and intestinal development in weaned goats during rumen-protected methionine treatmentYouli Wang, Wei Liu, An Li, et al.
Clinical Pharmacology in Drug Development|December 30, 2022
Pharmacokinetic Interaction of Chiglitazar with CYP3A4 Inducer or Inhibitor: An Open-Label, Sequential Crossover, Self-Control, 3-Period Study in Healthy Chinese VolunteersFei Yuan, Jing Li, Xuening Li, et al.
Clinical Pharmacology in Drug Development|July 5, 2022
Pharmacokinetics of Icosapent Ethyl: An Open-Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese SubjectsFei Yuan, Hui Li, Mengjie Yang, et al.
Drug Design, Development and Therapy|March 17, 2021
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy SubjectsLei Sheng, Wei Cao, Pingping Lin, et al.
Molecular Biology and Evolution|December 1, 2021
Evolution under Spatially Heterogeneous Selection in Solid TumorsGuanghao Li, Zuyu Yang, Dafei Wu, et al.
Drug Design, Development and Therapy|June 9, 2016
Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose studyHongrong Xu, Lei Sheng, Weili Chen, et al.
Frontiers in Pharmacology|September 8, 2022
Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gpTingting Zhao, Xuening Li, Yanwei Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2026
Detailed pharmacokinetic features of a novel bis-boron 18F-trifluoroborate acid in healthy volunteers: comparable and additional values of total-body PET-imaging-derived analysisGuobing Liu, Hongrong Xu, Jing Lv, et al.
Pageof 11